Tremelimumab
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer (NCT05120622) | University of British Columbia | 2021-09-01 |
Track Tremelimumab automatically
Every clearance here is in the API, with alerts when new ones post.